Staged stereotactic radiosurgery decreases symptomatic radionecrosis in large brain metastasis

2Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Background: Limited brain metastasis is treated definitively with stereotactic radiosurgery when surgical resection is not indicated. Although this has historically been performed in a single fraction, multi-fraction approaches such as fraction radiosurgery (FSRS) and staged radiosurgery (SSRS) have been recently examined as alternative approaches for larger lesions to permit better tumor control without increased toxicity. Case Report: We present the case of a patient who developed symptomatic radionecrosis in two brain metastasis, 2.3 cm and 2.1 cm in size, which were treated with 18 Gy in one fraction, but no radionecrosis in a 3.3 cm lesion treated in two fractions of 15 Gy nor in two punctate lesions that were treated in one fraction of 20 Gy. Although she did not respond to steroids, she responded to bevacizumab symptomatically and on neuroimaging. Conclusion: Congruent with other recent studies, our report suggests that large brain metastasis should be considered for FSRS/SSRS.

Cite

CITATION STYLE

APA

Chevli, N., Wang, H. C., Dubey, P., Haque, W., Farach, A. M., Pino, R., … Teh, B. S. (2021). Staged stereotactic radiosurgery decreases symptomatic radionecrosis in large brain metastasis. Anticancer Research, 41(3), 1445–1449. https://doi.org/10.21873/anticanres.14902

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free